Huang D.-C.YAO-HSU YANGYU-TSAN LINBOR-LUEN CHIANG2020-12-182020-12-1820030253-2662https://www.scopus.com/inward/record.uri?eid=2-s2.0-0037356906&partnerID=40&md5=5ebfbfa16125b25ac7ef1d474a77207ehttps://scholars.lib.ntu.edu.tw/handle/123456789/527304Henoch-Sch?nlein purpura is one of the most common types of systemic vasculitis in children. Although recurrence is frequent, most cases are benign and self-limited. Standard treatment consists of supportive care and nonsteroid antiinflammatory drugs and/or steroid. Here we report 2 cases of Henoch-Sch?nlein purpura, both of which had a prolonged and corticosteroid-dependent disease course. After treatment with cyclosporin A, the symptoms and signs subsided gradually in both cases with no recurrence after tapering of corticosteroid and cyclosporin A.[SDGs]SDG3azathioprine; corticosteroid; cyclosporin A; methylprednisolone sodium succinate; nonsteroid antiinflammatory agent; prednisolone; steroid; anaphylactoid purpura; article; case report; child; edema; human; kidney disease; male; moon face; recurrent disease; side effect; systemic vasculitis; weight gain; Child, Preschool; Cyclosporine; Humans; Immunosuppressive Agents; Male; Purpura, Schoenlein-Henoch; Steroids; Treatment Outcomejournal article127417362-s2.0-0037356906